Furthermore, we found that high LDH serum level was an independent predictor of PFS and OS in patients with the EGFR mutation; this may have been because serum LDH level is related to intratumoral angiogenesis, tumor invasion ability, and resistance to therapy [20–21]. The gene discussed is EGFR; the disease is neoplasm.